Your browser does not support JavaScript or it may be disabled!
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
Get Realtime News
on your webpage

About 805 results for "pfizer drugmaker pfizer"

Pssst... Pfizer Just Told Investors That This is the Next Big Thing
Motley Fool

Pssst... Pfizer Just Told Investors That This is the Next Big ...

Pfizer's vote of confidence in biosimilars -- the generic alternatives to biologic-based medicines such as AbbVie's megablockbuster drug Humira -- isn't misplaced. According to Frost & Sullivan, the biosimilar market is expected to surge from just ... Motley Fool, 1 week ago

14 images for pfizer drugmaker pfizer

One News Page United Kingdom, 3 weeks ago
Irish Independent, 3 weeks ago
Citybizlist, 2 weeks ago
Malaysian Insider, 3 weeks ago
Chicago Sun-Times, 3 weeks ago, 1 month ago
CNBC, 3 weeks ago
Asiaone, 1 month ago, 1 month ago, 1 month ago
Digital Journal

Hospira CEO May Walk Away With More Than $80 Million After Pfizer Deal is Finalized

Like many employees at Hospira, CEO Michael Ball is expected to be out of a job after Pfizer acquires the Lake Forest-based generic drugmaker. Unlike most of them, Ball should be able to afford a long stretch of unemployment. He appears likely to ...
 BioSpace2 weeks ago Pfizer to acquire Hospira in big pharma sale  Digital Journal2 weeks ago US Pharma Giant Pfizer Takes Over (Dollar) 17 Billion Hospira  24Dunia3 weeks ago Pfizer to buy Hospira at enterprise value of $17 bn  24Dunia3 weeks ago
Seeking Alpha

Pfizer Pays A Pretty Penny For Hospira: Here's What You Need To Know

Feb. 9, 2015 9:49 AM ET | About: Hospira, Inc. (HSP), Includes: ABT, EPRS, MYL, PFE, TARO, TEVA by: Brendan O'Boyle Summary Pfizer announced on Thursday that they will acquire Hospira for $90/share. This deal is examined in the context of ...
 Seeking Alpha3 weeks ago Pfizer To Buy Hospira At A Premium Of More Than 100% Above Its Intrinsic Value  Seeking Alpha3 weeks ago Pfizer Not Done With Deals Even After Hospira Purchase  Yahoo! Finance3 weeks ago Growth concerns loom for Daiichi Sankyo on drug warning  Japan Times3 weeks ago

Pfizer Inc. (PFE) Strikes A $5 Billion Accelerated Share Repurchase Deal With Goldman Sachs Group Inc

Pfizer Inc. ( NYSE:PFE ) announced it has entered into an accelerated share repurchase (ASR) agreement with Goldman, Sachs & Co. to buy back $5 billion worth of the company's common stock. This repurchase decision is part of the company's ASR ...
 Bidness Etc3 weeks ago Pfizer Entered Into $5 Bln Accelerated Share Repurchase Agreement  RTTNews.com3 weeks ago
Channel NewsAsia

Pfizer in US$5b accelerated buyback deal

REUTERS: Drugmaker Pfizer Inc said it entered into an agreement with Goldman, Sachs & Co to buy back US$5 billion of its stock. Pfizer said the accelerated share repurchase was assumed in the forecast for the full year it provided last month. ...
 Channel NewsAsia3 weeks ago Pfizer in $5 bln accelerated buyback deal with Goldman, Sachs & Co  CNBC3 weeks ago Pfizer in US$5 billion accelerated buyback deal with Goldman, Sachs & Co  Channel NewsAsia3 weeks ago Pfizer in $5 billion accelerated buyback deal with Goldman, Sachs & Co  Yahoo! UK and Ireland3 weeks ago

Pfizer profit beats estimates; lowers outlook

Drugmaker Pfizer reported stronger-than-expected quarterly revenue results, but forecast a blow to 2015 earnings because of patent expirations and the impact of a stronger dollar. The New York City company, which is the largest U.S. drugmaker, said ...
 USA Today1 month ago Pfizer Sales Suffer From Patent Losses, Stronger Dollar  Forbes.com1 month ago PFIZE : Pfizer  4 Traders1 month ago Pfizer : 2015 forecast disappoints, crimped by generics, dollar  4 Traders1 month ago

Pfizer beats estimates

Pfizer Inc, the biggest US drugmaker, beat analyst's profit and sales estimates as sales of products including the vaccine Prevnar surpassed expectations. Oct-Dec quarter profit, excluding one-time items, beat by one cent the 53-cent average of 17 ...
 Business Standard India1 month ago Pfizer Beats Earnings Estimates as Vaccine Sales Increase  Bloomberg1 month ago
Epoch Times

Pfizer net down on lower sales, higher research, legal costs

Listen LINDA A. JOHNSON New York Pfizer Inc.'s fourth-quarter profit fell by half as worsening generic competition and unfavourable currency rates reduced sales, and higher research and legal costs also reduced the bottom line. The world's ...
 Gulf Time UAE4 weeks ago Pfizer Inc. (PFE) Q4 Earnings Preview: High Organic Growth In Vaccines And Oncology To Offset Loss Of Patents  Bidness Etc1 month ago Pfizer Fourth-Quarter Profits Down 50 Percent on Lower Sales, Higher Research, Legal Costs  Epoch Times1 month ago Pfizer Inc.'s Fourth-Quarter Earnings Hint at Big Things to Come  Nasdaq1 month ago
Motley Fool

Deal-Hungry Pfizer Won't Stop With Hospira; Who Could Be Next?

After being spurned repeatedly by British drugmaker AstraZeneca, Pfizer recently anted up $17 billion for a much smaller drug company, Hospira (NYSE: HSP While the acquisition surprised almost everyone, I think it's a savvy move. Hospira will allow ...
 Motley Fool2 weeks ago

Will Pfizer Inc. Break Up in 2015?

The pharma giant's stock is seemingly stuck in a rut, largely because of the loss of exclusivity for former top sellers such as Celebrex and Lipitor. But the truth is slightly more complex. Pfizer has been churning out major new products such as ...
 Motley Fool2 weeks ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts


Realtime News

on your Webpage

Add Widget >Get your members hooked!
Get updated on latest news & your favorite topics right in your inbox!
Happening by Location Click on any location on map to view latest news by location
More     Less